Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Interventional Cardiology Physician in Ocala, FL
NPI: 1063448488Primary Practice Location
HCA FLORIDA CITRUS HOSPITAL
502 W Highland Blvd, Inverness, FL
Primary Employer
Cardiovascular Institute of Central Florida, LLC
cvicfl.com
HQ Phone
Get M.D. Siva's Phone Numberphone_androidMobile
Get M.D. Siva's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1997 - 2027
AZ State Medical License
2003 - 2005
IL State Medical License
1992 - 2005
American Board of Internal Medicine
Cardiovascular Disease
Chicago Medical School/Rosalind Franklin University of Medicine & Science
Fellowship • Cardiovascular Disease
1998 - 2001
Residency • Internal Medicine
1993 - 1996
Guntur Medical College NTR
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 1,139 | 2,441 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 964 | 1,063 |
| 3 | 93880Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | 476 | 497 |
| 4 | 93015Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report | 325 | 325 |
| 5 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 319 | 321 |
Authors: Robert Sanchez, Michael Robertson, Orvar Jonsson, Byron Colley
Journal: Eur Heart J
Increased Quality of Life Among Newly Diagnosed Patients With Heart Failure With Reduced Ejection Fraction in the Months After Initiation of Guideline-Directed Medical Therapy and Wearable Cardioverter Defibrillator Prescription.
Authors: Michael Robertson
Publication Date: 2021-10-05
Lead Sponsor: AstraZeneca
Intervention / Treatment: DRUG: Clopidogrel, DRUG: Ticagrelor
Lead Sponsor: American Regent, Inc.
Collaborators: Duke Clinical Research Institute
Intervention / Treatment: DRUG: Placebo, DRUG: Ferric Carboxymaltose
